Kevin Ferro

Business address
C/O Kos Pharmaceuticals, Inc., 1001 Brickell Bay Drive, 25 Th Floor, Miami, FL, 33131
Top holdings (ownership)
GHL
Get insider transactions for this reporting owner
Kevin Ferro has filed 27 SEC EDGAR filings since 02 Aug 2004

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing 01 Dec 2023 30 Nov 2023 001-32147
4 Open Document Open Filing FORM 4 05 Apr 2023 03 Apr 2023 001-32147
4 Open Document Open Filing FORM 4 05 Jan 2023 04 Jan 2023 001-32147
4 Open Document Open Filing FORM 4 06 Oct 2022 04 Oct 2022 001-32147
4 Open Document Open Filing FORM 4 07 Jul 2022 05 Jul 2022 001-32147
4 Open Document Open Filing FORM 4 04 May 2022 02 May 2022 001-32147
4 Open Document Open Filing FORM 4 SUBMISSION 06 Apr 2022 05 Apr 2022 001-32147
4 Open Document Open Filing FORM 4 SUBMISSION 05 Jan 2022 04 Jan 2022 001-32147
4 Open Document Open Filing FORM 4 SUBMISSION 07 Oct 2021 05 Oct 2021 001-32147
4 Open Document Open Filing FORM 4 SUBMISSION 06 Jul 2021 02 Jul 2021 001-32147
4 Open Document Open Filing FORM 4 SUBMISSION 11 May 2021 07 May 2021 001-32147
4 Open Document Open Filing FORM 4 SUBMISSION 06 Apr 2021 06 Apr 2021 001-32147
4 Open Document Open Filing FORM 4 SUBMISSION 09 Mar 2021 05 Mar 2021 001-32147
3 Open Document Open Filing FORM 3 SUBMISSION 09 Mar 2021 05 Mar 2021 001-32147
4 Open Document Open Filing FORM 4 12 Jun 2019 11 Jun 2019 001-35405
4 Open Document Open Filing FORM 4 SUBMISSION 26 Feb 2019 22 Feb 2019 001-35405
4 Open Document Open Filing FORM 4 SUBMISSION 14 Jun 2018 12 Jun 2018 001-35405
4 Open Document Open Filing FORM 4 SUBMISSION 31 May 2018 29 May 2018 001-35405
4 Open Document Open Filing FORM 4 SUBMISSION 09 Jan 2018 05 Jan 2018 001-35405
3 Open Document Open Filing FORM 3 13 Nov 2017 03 Nov 2017 001-35405